Fundraising Fox

Huya Bioscience International

San Diego, US · Founded 2004 · Delaware LLC · 129 employees on LinkedIn

HUYABIO International develops novel biopharmaceutical products originating in China for global markets, working with biopharmaceutical, academic and commercial partners to advance drug candidates across all therapeutic areas. It maintains a large China-sourced compound portfolio and operates offices across the US, Japan, South Korea, Canada, Ireland and China.

Founders & leadership

Huya Bioscience International was founded in 2004 by Mireille Gillings.

MGMireille Gillings
Mireille GillingsChief Executive Officer & Executive Chair
CG
Clement GingrasExecutive
JSJohn Sharp
John SharpinCFO2014–2015

Board

RM
Robert M. HaimsohnBoard director
MM
Michael MortimerBoard director
DW
Derek WinstanlyBoard director

Reported raises · per SEC filings

Form D private placements

$48M disclosed across 1 round · 2013

$48MraisedApr 2015 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clement GingrasExecutive Officer, Director
  • Robert M. HaimsohnDirector
  • Michael MortimerDirector
  • John SharpExecutive Officer
  • Derek WinstanlyDirector
  • Mireille GillingsExecutive Officer, Director
Offering amount
$48M
Amount sold
$48M
Minimum investment
$200K
First sale
Sep 2013
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Huya Bioscience International went on to found or lead other companies.

Competitors · 1

by search overlap

Companies competing with Huya Bioscience International for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Huya Bioscience International do?
HUYABIO International develops novel biopharmaceutical products originating in China for global markets, working with biopharmaceutical, academic and commercial partners to advance drug candidates across all therapeutic areas. It maintains a large China-sourced compound portfolio and operates offices across the US, Japan, South Korea, Canada, Ireland and China.
Who founded Huya Bioscience International?
Huya Bioscience International was founded by Mireille Gillings in 2004.
How much funding has Huya Bioscience International raised?
Huya Bioscience International has disclosed $48M raised across 1 round.
Where is Huya Bioscience International headquartered?
Huya Bioscience International is headquartered in San Diego, US.